Gene and Cell Therapy for Parkinson's: Where Things Actually Stand

Gene therapy and cell therapy carry the biggest promise in Parkinson's research: not just managing symptoms, but repairing or protecting the brain itself. They are also among the earliest-stage and most misunderstood parts of the field, and the space where dishonest clinics do the most damage. None of this is a cure available today, but understanding it helps you tell genuine research apart from the clinics that sell unproven "stem cell cures." You can track every program on the drug pipeline tracker.

Gene Therapy vs. Cell Therapy

Cell therapy replaces what has been lost: it grows new dopamine-producing neurons in a lab and surgically places them into the brain. Gene therapy changes the instructions inside existing cells, usually delivering a gene via a harmless virus so cells produce a protective substance, as a one-time treatment. Both require neurosurgery, both are experimental, and neither has been shown to slow or reverse Parkinson's in a large controlled trial.

Cell Therapy: Replacing Lost Neurons

Bemdaneprocel (BlueRock, a Bayer company) is the most advanced. Its small Phase 1 study, designed mainly to test safety, reported the procedure was generally safe with exploratory hints of motor improvement at one year in a handful of people; a larger controlled trial is planned. ANPD001 (Aspen Neuroscience) is made from each patient's own cells to avoid immune-suppressing drugs; early six-month data from the first three patients in its ASPIRO trial were reported in 2025 as safe and well tolerated. Surgical Parkinson's trials carry a strong placebo effect, so only a controlled trial can prove benefit. See our deeper look at stem cell therapy.

Gene Therapy: Reprogramming the Brain's Own Cells

AB-1005 (AskBio, a Bayer company) is a one-time gene therapy delivering GDNF, a growth factor, into the brain to support dopamine neurons. It has been studied in a small Phase 1b trial focused on safety and feasibility. Earlier attempts to deliver GDNF by other methods did not clearly beat placebo, which is why researchers now insist on careful controlled trials.

A Warning About "Stem Cell" Clinics

Clinics, often overseas, that sell "stem cell therapy for Parkinson's" today for tens of thousands of dollars are not the same as legitimate trials. They are typically unproven, unregulated, and sometimes dangerous. Real cell and gene therapy is available only through clinical trials, at no cost to the participant. If someone is charging you for a stem cell cure, that is the warning sign. See how to spot a questionable trial and alpha-synuclein explained.